MOMETASONE CREAM 0.1% 30G

Mometasone-Akrihin (cream)

INN:

mometasone

Pharmacotherapeutic group:

glucocorticosteroid for topical use.

Indications for use.

Inflammation and pruritus in dermatoses, susceptible to glucocorticosteroid therapy.

Contraindications

- Hypersensitivity to any component of the drug or glucocorticosteroid drugs.
- Pink acne, perioral dermatitis.
- Bacterial, viral (Herpes simplex, chicken pox, Herpes zoster) or a fungal infection of the skin.
- Tuberculosis, syphilis.
- Vaccination reactions.
- Children's age up to 6 months.
- Pregnancy (treatment of large areas of skin, long-term treatment).
- Lactation period (use in large doses or / and for a long time).
Carefully. Applying to the skin of the face and in the folds, the use of occlusive dressings, as well as the treatment of large areas of skin and / or long-term treatment (especially in children).

Use during pregnancy and lactation

The safety of using Mometasone-Akrikhin cream during pregnancy and lactation has not been studied. Glucocorticosteroids penetrate the placental barrier.
Long-term treatment and the use of large doses during pregnancy should be avoided due to the threat of a negative impact on fetal development. Glucocorticosteroids are excreted in breast milk.In the case when the use of GCS in high doses and / or for a long time is expected, breastfeeding should be stopped.

Dosage and administration

Outwardly. A thin layer of cream Mometasone-Akrihin applied to the affected skin once a day. The duration of the course of treatment is determined by its effectiveness, as well as by the tolerance of the patient, the presence and severity of side effects.

Side effects

Rarely - irritation and dryness of the skin, burning sensation, itching, folliculitis, hypertrichosis, acne, hypopigmentation, perioral dermatitis, allergic contact dermatitis, skin maceration, the attachment of a secondary infection, signs of skin atrophy, stretch marks, prickly pears. In less than 1% of cases - the formation of papules, pustules. When applying the cream Mometasone-Akrikhin for a long time and / or for the treatment of large areas of the skin, or using occlusive dressings, especially in children and adolescents, side effects can occur that are characteristic of GCS systemic action, including adrenal insufficiency and Cushing's syndrome.

Release form

Cream for external use of 0.1%. On 15 and 30 g in a tuba aluminum. Each tube together with instructions for use is placed in a pack of cardboard.

Storage conditions

At a temperature of 15 to 25 ° C. Keep out of the reach of children.